NCT05539144View on ClinicalTrials.gov

A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 11, 2021

Primary Completion Date

December 11, 2022

Study Completion Date

December 11, 2023

Conditions
Head and Neck CancerRadiotherapyOropharynx AbnormalityRadiotherapy; Adverse Effect
Interventions
RADIATION

"Oropharyngeal mucosa"

"Oropharyngeal mucosa was delineated as OARs and limiting its dose"

RADIATION

oropharynx

oropharynx was delineated as OARs and limiting its dose

RADIATION

"oropharynx and oropharyngeal mucosa"

"oropharynx and oropharyngeal mucosawere delineated as OARs and limiting its dose"

Trial Locations (1)

050011

Department of Radiotherapy, Hebei Province Hospital of Chinese Medicine, Shijiazhuang

All Listed Sponsors
lead

Hebei Provincial Hospital of Traditional Chinese Medicine

OTHER_GOV

NCT05539144 - A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer | Biotech Hunter | Biotech Hunter